Dialysis-related adverse reactions can be serious and difficult to predict. In our case, nafamostat mesylate (NM) was thought to be the cause of cardiopulmonary arrest (CPA) due to NM-induced anaphylaxis but was not reflected in the allergy tests. Rare but life-threatening drawbacks occur immediately after hemodialysis initiation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314566 | PMC |
| http://dx.doi.org/10.1002/ccr3.6140 | DOI Listing |
Publication Analysis
Top Keywords
cardiopulmonary arrest
8
nafamostat mesylate
8
arrest caused
4
caused nafamostat
4
mesylate hemodialysis
4
hemodialysis dialysis-related
4
dialysis-related adverse
4
adverse reactions
4
reactions serious
4
serious difficult
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!